Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer

PURPOSE: There are sparse data describing outcomes of bone-only oligometastatic prostate cancer in comparison with lymph node disease treated with stereotactic body radiotherapy (SBRT). The primary aim of this study was to report progression-free survival (PFS) data for patients with bone-only disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Priyanka H., Chaw, Cheng Lee, Tree, Alison C., Sharabiani, Mansour, van As, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868044/
https://www.ncbi.nlm.nih.gov/pubmed/31346760
http://dx.doi.org/10.1007/s00345-019-02873-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868044/
https://www.ncbi.nlm.nih.gov/pubmed/31346760
http://dx.doi.org/10.1007/s00345-019-02873-w

Ejemplares similares